Germline polymorphisms in MGMT associated with temozolomide-related myelotoxicity risk in patients with glioblastoma treated on NRG Oncology/RTOG 0825.
Neuro-Oncology Advances
Scheurer, Michael E ME; Zhou, Renke R; Gilbert, Mark R MR; Bondy, Melissa L ML; Sulman, Erik P EP; Yuan, Ying Y; Liu, Yanhong Y; Vera, Elizabeth E; Wendland, Merideth M MM; Youssef, Emad F EF; Stieber, Volker W VW; Komaki, Ritsuko R RR; Flickinger, John C JC; Kenyon, Lawrence C LC; Robins, H Ian HI; Hunter, Grant K GK; Crocker, Ian R IR; Chao, Samuel T ST; Pugh, Stephanie L SL; Armstrong, Terri S TS